A18.17

A18.17: Tuberculous female pelvic inflammatory disease

Billable / specific codeICD-10-CM

A18.17 is a billable, specific ICD-10-CM code for tuberculous female pelvic inflammatory disease. It is valid for submission on a claim.

Check A18.17 with the rest of the claim: free scrubber

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Tuberculous endometritis
Tuberculous oophoritis and salpingitis

Other codes that can never be billed with A18.17

Their own Excludes1 notes name this code, so the conflict is not listed above.

N70Salpingitis and oophoritis
N73.1Chronic parametritis and pelvic cellulitis
N73.4Female chronic pelvic peritonitis
N74Female pelvic inflammatory disorders in diseases classified elsewhere

Risk adjustment

No CMS-HCC V28 category: this code does not change a RAF score.

Medicare coverage

A18.17 is named in 10 Medicare coverage policies: 10 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

A56416Billing and Coding: Assays for Vitamins and Metabolic Function
A56421Billing and Coding: CT of the Abdomen and Pelvis
A56841Billing and Coding: Vitamin D; 25 hydroxy, includes fraction(s), if performed
A57484Billing and Coding: Vitamin D Assay Testing

Alphabetic index entries that lead here

Endometritis›tuberculous
Salpingitis›tuberculous(acute) (chronic)
Salpingo-oophoritis›tuberculous(acute) (chronic)
Tuberculosis, tubercular, tuberculous›adnexa(uteri)
Tuberculosis, tubercular, tuberculous›broad ligament
Tuberculosis, tubercular, tuberculous›cul-de-sac of Douglas
Tuberculosis, tubercular, tuberculous›endometrium
Tuberculosis, tubercular, tuberculous›fallopian tube(acute) (chronic)
Tuberculosis, tubercular, tuberculous›female pelvic inflammatory disease
Tuberculosis, tubercular, tuberculous›oophoritis(acute) (chronic)
Tuberculosis, tubercular, tuberculous›ovary, ovaritis(acute) (chronic)
Tuberculosis, tubercular, tuberculous›oviduct(acute) (chronic)

Code history

Unchanged in every release from FY2024 to FY2027.